Goserelin acetate before transurethral resection of moderately enlarged benign prostatic hyperplasia: Prospective randomised-controlled clinical trial
Conclusion A single dose of GA, a LHRH agonist, before TURP is safe and effective in reducing surgical blood loss. It significantly reduced MVD in both suburethral and stromal nodular prostatic tissues without regional discrepancy.
Source: Arab Journal of Urology - Category: Urology & Nephrology Source Type: research
More News: Benign Prostatic Hyperplasia | Clinical Trials | Hormones | Middle East Health | Urology & Nephrology